Posted inMetabolism, New Drugs, Regulatory Camzyos: First Specific Drug to Treat Hypertrophic Cardiomyopathy April 29, 2022August 4, 2022 Mavacamten by Bristol-Myers Squibb is a new breath for all patients with obstructive hypertrophic cardiomyopathy.
